Treatment Of Radiation Retinopathy Trial

NCT00811200 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DRUG: ranibizumab
DRUG: triamcinolone acetonide
OTHER: sham

Sponsor

Leiden University Medical Center

Collaborators

[object Object]